• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植的间充质干细胞与纯纤维蛋白明胶转化生长因子-β1 可减少兔椎间盘退变。

Transplanted mesenchymal stem cells with pure fibrinous gelatin-transforming growth factor-beta1 decrease rabbit intervertebral disc degeneration.

机构信息

The First Affiliated Hospital of Suzhou University, Suzhou 215006, China.

出版信息

Spine J. 2010 Sep;10(9):802-10. doi: 10.1016/j.spinee.2010.06.019. Epub 2010 Jul 24.

DOI:10.1016/j.spinee.2010.06.019
PMID:20655810
Abstract

BACKGROUND CONTEXT

Disc degeneration is a major reason for low back pain and can be caused by apoptosis. The prevention of apoptosis using mesenchymal stem cells (MSCs) may lead to new treatments for low back pain. Previous studies have reported that transplanted MSCs can proliferate and differentiate into cells expressing some of the major phenotypic qualities of nucleus pulposus cells. However, the effects of MSC transplantation on the disc height index (DHI) and apoptosis inhibition have not yet been thoroughly investigated.

PURPOSE

The present study evaluates the effects of MSC transplantation on DHI and its potential to inhibit apoptosis.

STUDY DESIGN/SETTING: Random, controlled, animal experiment study.

METHODS

The annulus fibrosus of 54 white New Zealand rabbits was punctured with a 21-gauge needle, and the nucleus pulposus tissue from the intervertebral discs was aspirated. The degenerative disc model was produced in each rabbit, which were then randomly divided into three groups: degenerative model group; pure fibrinous gelatin-transforming growth factor-beta1 (PFG-TGF-beta1) transplanted group; and MSC-PFG-TGF-beta1 transplanted group. Computed radiography imaging, magnetic resonance imaging, and histological examinations were performed at Weeks 4, 8, and 12.

RESULTS

The transplanted MSCs inhibited apoptosis and slowed the rate of decrease in DHI. Magnetic resonance imaging results showed that the MSC-PFG-TGF-beta1 group had less degeneration and a slower decrease in DHI compared with both the degenerative model and PFG-TGF-beta1 groups. An increased quantity of nucleus pulposus and type II collagen content and a decrease in the rate of cell apoptosis were noted in the MSC-PFG-TGF-beta1 group.

CONCLUSIONS

Mesenchymal stem cells can slow the rate at which the DHI decreases. This effect may be because of the inhibition of apoptosis by MSCs.

摘要

背景

椎间盘退变是腰痛的主要原因,可由细胞凋亡引起。使用间充质干细胞(MSCs)预防细胞凋亡可能为腰痛的治疗提供新的途径。先前的研究已经报道,移植的 MSCs 可以增殖并分化为表达一些核髓核细胞主要表型特征的细胞。然而,MSCs 移植对椎间盘高度指数(DHI)和抑制细胞凋亡的影响尚未得到彻底研究。

目的

本研究评估 MSCs 移植对 DHI 的影响及其抑制细胞凋亡的潜力。

研究设计/设置:随机、对照、动物实验研究。

方法

用 21 号针头穿刺 54 只白色新西兰兔的纤维环,抽吸椎间盘的髓核组织。在每只兔子中产生退行性椎间盘模型,然后将其随机分为三组:退行性模型组;单纯纤维蛋白明胶转化生长因子-β1(PFG-TGF-β1)移植组;MSC-PFG-TGF-β1 移植组。在第 4、8 和 12 周进行计算机放射成像、磁共振成像和组织学检查。

结果

移植的 MSCs 抑制了细胞凋亡并减缓了 DHI 的下降速度。磁共振成像结果显示,与退行性模型组和 PFG-TGF-β1 组相比,MSC-PFG-TGF-β1 组退变程度较轻,DHI 下降速度较慢。MSC-PFG-TGF-β1 组可见髓核数量增加、Ⅱ型胶原含量增加,细胞凋亡率降低。

结论

间充质干细胞可以减缓 DHI 下降的速度。这种作用可能是由于 MSCs 抑制了细胞凋亡。

相似文献

1
Transplanted mesenchymal stem cells with pure fibrinous gelatin-transforming growth factor-beta1 decrease rabbit intervertebral disc degeneration.移植的间充质干细胞与纯纤维蛋白明胶转化生长因子-β1 可减少兔椎间盘退变。
Spine J. 2010 Sep;10(9):802-10. doi: 10.1016/j.spinee.2010.06.019. Epub 2010 Jul 24.
2
Coculture of synovium-derived stem cells and nucleus pulposus cells in serum-free defined medium with supplementation of transforming growth factor-beta1: a potential application of tissue-specific stem cells in disc regeneration.在添加转化生长因子-β1的无血清限定培养基中滑膜来源干细胞与髓核细胞的共培养:组织特异性干细胞在椎间盘再生中的潜在应用
Spine (Phila Pa 1976). 2009 May 20;34(12):1272-80. doi: 10.1097/BRS.0b013e3181a2b347.
3
Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs.富血小板血浆和可生物降解明胶水凝胶微球对退变椎间盘体内作用的表征。
Tissue Eng Part A. 2009 Dec;15(12):3719-27. doi: 10.1089/ten.TEA.2008.0697.
4
Possible pathogenesis of painful intervertebral disc degeneration.疼痛性椎间盘退变的可能发病机制。
Spine (Phila Pa 1976). 2006 Mar 1;31(5):560-6. doi: 10.1097/01.brs.0000201324.45537.46.
5
Feasibility of a stem cell therapy for intervertebral disc degeneration.一种用于椎间盘退变的干细胞疗法的可行性。
Spine J. 2008 Nov-Dec;8(6):888-96. doi: 10.1016/j.spinee.2007.09.011. Epub 2007 Dec 21.
6
Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model.在异种猪模型中将人间充质干细胞移植到椎间盘内。
Spine (Phila Pa 1976). 2009 Jan 15;34(2):141-8. doi: 10.1097/BRS.0b013e31818f8c20.
7
Feasibility of using a human nucleus pulposus cell line as a cell source in cell transplantation therapy for intervertebral disc degeneration.在椎间盘退变的细胞移植治疗中使用人髓核细胞系作为细胞来源的可行性。
Spine (Phila Pa 1976). 2006 May 15;31(11):1177-86. doi: 10.1097/01.brs.0000217687.36874.c4.
8
[Restraining degeneration of punctured intervertebral discs by transplantation of rabbit nucleus pulposus cells and marrow stroma cells].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):472-7.
9
Autologous stem cell therapy maintains vertebral blood flow and contrast diffusion through the endplate in experimental intervertebral disc degeneration.自体干细胞治疗通过终板维持实验性椎间盘退变中的椎骨血流和对比扩散。
Spine (Phila Pa 1976). 2011 Mar 15;36(6):E373-9. doi: 10.1097/BRS.0b013e3181dce34c.
10
Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model.在大鼠椎间盘损伤模型中,嗅觉干细胞可被诱导表达软骨生成表型。
Spine J. 2009 Jul;9(7):585-94. doi: 10.1016/j.spinee.2009.02.011. Epub 2009 Apr 5.

引用本文的文献

1
Tissue engineering strategies for treating intervertebral disc degeneration.治疗椎间盘退变的组织工程策略
Front Bioeng Biotechnol. 2025 Jul 14;13:1582189. doi: 10.3389/fbioe.2025.1582189. eCollection 2025.
2
Advancements in Degenerative Disc Disease Treatment: A Regenerative Medicine Approach.退行性椎间盘疾病治疗的进展:一种再生医学方法。
Stem Cell Rev Rep. 2025 Apr 15. doi: 10.1007/s12015-025-10882-z.
3
High impact works on stem cell transplantation in intervertebral disc degeneration.关于干细胞移植治疗椎间盘退变的高影响力研究。
BMC Musculoskelet Disord. 2024 Dec 19;25(1):1029. doi: 10.1186/s12891-024-08131-4.
4
TGF-β1 Inhibits Osteoclast Differentiation and Abnormal Angiogenesis in Intervertebral Disc Degeneration: Evidence from RNA Sequencing and Animal Studies.TGF-β1 通过 RNA 测序和动物研究抑制椎间盘退变中的破骨细胞分化和异常血管生成。
Orthop Surg. 2024 Jan;16(1):167-182. doi: 10.1111/os.13912. Epub 2023 Nov 28.
5
Salvianolic acid B combined with bone marrow mesenchymal stem cells piggybacked on HAMA hydrogel re-transplantation improves intervertebral disc degeneration.丹参酚酸B联合负载于透明质酸微球水凝胶上的骨髓间充质干细胞再移植可改善椎间盘退变。
Front Bioeng Biotechnol. 2022 Sep 27;10:950625. doi: 10.3389/fbioe.2022.950625. eCollection 2022.
6
Evaluation of the Efficacy of Stem Cell Therapy in Animal Models of Intervertebral Disc Degeneration Based on Imaging Indicators: A Systematic Review and Meta-Analysis.基于影像学指标评估干细胞疗法在椎间盘退变动物模型中的疗效:一项系统评价和Meta分析
Stem Cells Int. 2022 Aug 31;2022:2482653. doi: 10.1155/2022/2482653. eCollection 2022.
7
The role of microenvironment in stem cell-based regeneration of intervertebral disc.微环境在基于干细胞的椎间盘再生中的作用。
Front Bioeng Biotechnol. 2022 Aug 9;10:968862. doi: 10.3389/fbioe.2022.968862. eCollection 2022.
8
Development of a stem cell spheroid-laden patch with high retention at skin wound site.一种在皮肤伤口部位具有高滞留性的载干细胞球体贴片的研发。
Bioeng Transl Med. 2021 Dec 28;7(2):e10279. doi: 10.1002/btm2.10279. eCollection 2022 May.
9
Elucidating the Focal Immunomodulatory Clues Influencing Mesenchymal Stem Cells in the Milieu of Intervertebral Disc Degeneration.阐明影响椎间盘退变微环境中间充质干细胞的焦点免疫调节线索。
Curr Stem Cell Res Ther. 2023;18(1):62-75. doi: 10.2174/1574888X17666220420134619.
10
Biomaterials and Cell-Based Regenerative Therapies for Intervertebral Disc Degeneration with a Focus on Biological and Biomechanical Functional Repair: Targeting Treatments for Disc Herniation.用于椎间盘退变的生物材料和基于细胞的再生疗法,重点关注生物学和生物力学功能修复:针对椎间盘突出症的靶向治疗。
Cells. 2022 Feb 9;11(4):602. doi: 10.3390/cells11040602.